VOGLIGOLD 0.3

Voglibose 0.3 mg is an oral anti-diabetic drug from the alpha-glucosidase inhibitor class. It helps control postprandial blood sugar levels by delaying carbohydrate digestion and glucose absorption in the small intestine.VOGLIGOLD 0.3, manufactured by Steris Healthcare, offers reliable control for patients with Type 2 Diabetes when combined with proper diet, exercise, and, if necessary, other anti-diabetic medicines.

Uses of Voglibose 0.3 mg Tablets

The primary voglibose tablet uses include:

• Management of Type 2 Diabetes Mellitus.

• Control of post-meal hyperglycemia.

• Used in combination with other anti-diabetic drugs or insulin for better blood sugar regulation.

• Prevention of diabetes-related complications like heart disease, kidney damage, nerve issues, and vision problems.

Side Effects of Voglibose 0.3 mg

While voglibose 0.3 mg is generally well-tolerated, it may cause side effects in some patients. These can include:

• Abdominal pain or discomfort

• Flatulence (excess gas)

• Diarrhea

• Bloating

• Nausea

• Indigestion (dyspepsia)

• Loss of appetite

• Mild skin rash or itching

• Constipation (in rare cases)

• Fatigue

• Headache

• Dizziness

• Increased bowel sounds (borborygmi)

• Rarely, low blood sugar (hypoglycemia), especially when taken with sulfonylureas or insulin

Note: Most gastrointestinal side effects occur in the first 2–3 weeks and may reduce as the body adapts to the medicine. If symptoms persist, seek medical attention.

Precautions Before Using Voglibose Tablets

Before taking voglibose tablets, let your doctor know if you:

• Have severe kidney or liver problems.

• Suffer from inflammatory bowel disease or chronic intestinal conditions.

• Have a history of intestinal obstruction or digestion disorders.

• Are pregnant, planning pregnancy, or breastfeeding.

• Are following a very low-carb diet (higher risk of hypoglycemia).

Drug Interactions – What Drugs Interact with Voglibose 0.3 mg?

Some medicines can affect the action of voglibose 0.3 mg or increase side effects:

• Sulfonylureas (e.g., glimepiride, glibenclamide) – may cause low blood sugar.

• Insulin – increased risk of hypoglycemia.

• Digestive enzymes (e.g., amylase, pancreatin) – reduce voglibose’s effect.

• Activated charcoal – lowers voglibose absorption.

• Other alpha-glucosidase inhibitors – increase GI side effects.